Objective Evaluation of the Number of Use Hour of Oxygen Therapy in Patients Receiving Supplemental Oxygen

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04204031

Acronym

MONOX

Enrollment

Registered

2019-12-18

Start date

2020-01-02

Completion date

2020-09-30

Last updated

2019-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Chronic Respiratory Failure With Hypoxia

Keywords

Long term oxygen therapy, adherence, electronic monitoring

Brief summary

The aim of this study is to measure the actual use time in patients receiving supplemental oxygen using a new easy-to-use electronic remote monitoring device (TeleOx™)

Detailed description

The first phase of the study is observational. Oxygen use time of patients with chronic respiratory failure under long term oxygen therapy will be objectively measured using a electronic remote monitoring device (TeleOx™) over 15 days. The actual use time will be compared to their oxygen prescription. Participants whose actual time of use will be less than prescribed will be offered an intervention which will consist of a presentation of the adherence record. The participant will also be asked about the presence of possible barriers concerning the use of oxygen therapy. The collaborator in charge of home visits will attempt to resolve these barriers as much as possible. Only participants with an actual time of use less than prescribed will be offered this intervention and will continue the monitoring over a period of 15 additional days.

Interventions

BEHAVIORALPresentation of the adherence record

Adherence record will be presented to participants with an actual time of use less than prescribed. The participant will also be asked about the presence of possible barriers concerning the use of oxygen therapy. The collaborator in charge of home visits will attempt to resolve these barriers as much as possible.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Long term oxygeno-therapy patients in stable condition without pulmonary exacerbation in the month before inclusion * Oxygen prescription for at least 15 hours/day

Exclusion criteria

* under 18 years old

Design outcomes

Primary

Measure	Time frame	Description
Oxygen use time	15 days	Average oxygen use time (hours/day) measured with a TeleOx device

Countries

Switzerland

Contacts

Primary ContactOlivier Contal, PhD

olivier.contal@hesav.ch+41213168122

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026